5 results match your criteria: "University of Pennsylvania and the Perelman School of Medicine[Affiliation]"
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry.
Circulation
October 2024
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy (N.M., C.F., I.O.).
Article Synopsis
- Septal reduction therapy (SRT) significantly improves symptoms for patients with obstructive hypertrophic cardiomyopathy (HCM), but its long-term results and predictors of adverse outcomes still need more study.* -
- An analysis of data from the SHARE registry revealed that among 1,832 patients who underwent SRT, the 30-day mortality rate was low at 0.4%, and after approximately 6.8 years, rates for HCM-related death, heart failure, and ventricular arrhythmias were relatively low.* -
- Key findings included that older age at SRT increases risks for HCM death and heart failure outcomes, while female patients showed higher susceptibility to heart failure complications post-treatment.*
Conjugated hyperbilirubinemia is associated with increased morbidity and mortality after neonatal heart surgery.
Cardiol Young
May 2024
Division of Cardiothoracic Surgery, Department of Surgery, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Background: Cholestasis characterised by conjugated hyperbilirubinemia is a marker of hepatobiliary dysfunction following neonatal cardiac surgery. We aimed to characterise the incidence of conjugated hyperbilirubinemia following neonatal heart surgery and examine the effect of conjugated hyperbilirubinemia on post-operative morbidity and mortality.
Methods: This was a retrospective study of all neonates who underwent surgery for congenital heart disease (CHD) at our institution between 1/1/2010 and 12/31/2020.
Evolution in reimbursement for sleep studies and sleep centers.
Chest
March 2015
Department of Medicine and the Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania and the Perelman School of Medicine, Philadelphia, PA.
Because of the rapid increase in the volume and costs of polysomnography and other sleep medicine diagnostic services, the Centers for Medicare & Medicaid Services (CMS) recently commissioned the Office of Inspector General (OIG) to review claims submitted for these services. The OIG found numerous cases of inappropriate payment for submitted claims and recommended significant changes in the CMS auditing process for polysomnography claims review. Additionally, a local Medicare Administrative Contractor released the most specific rules and regulations to date regarding billing and payment for sleep medicine services.
View Article and Find Full Text PDFTranscatheter therapy of mitral regurgitation.
Circulation
November 2014
From the Hospital of the University of Pennsylvania and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (H.C.H.); and the Department of Cardiovascular Surgery, University Hospital Zurich, Zurich, Switzerland (F.M.).
Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study.
J Vasc Interv Radiol
June 2014
Boston Scientific, Natick, Massachusetts.
Purpose: To assess the efficacy of two embolic agents in the treatment of symptomatic uterine leiomyomas.
Materials And Methods: A randomized, prospective, single-center study enrolled 60 women with symptomatic uterine leiomyomas. Uterine artery embolization (UAE) with spherical polyvinyl alcohol (SPVA) microspheres (n = 30; 700-900 μm and 900-1,200 μm; near-stasis or stasis endpoint) and tris-acryl gelatin (TAG) microspheres (n = 30; 500-700 μm; "pruned-tree" endpoint) was performed.